NEW YORK ( TheStreet) -- Amsurg Corporation (Nasdaq: AMSG) hit a new 52-week high Monday as it traded at $24.95 compared with its previous 52-Week high of $24.93. Amsurg is changing hands at $24.93 with 20,753 shares traded as of 10:06 a.m. ET. Average volume has been 139,500 shares over the past 30 days.

Amsurg has a market cap of $765.7 million and is part of the health care sector and health services industry. Shares are up 17.5% year to date as of the close of trading on Friday.

AmSurg Corp., through its wholly owned subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers in partnership with physicians in the United States. The company has a P/E ratio of 14.5, below the average health services industry P/E ratio of 15.1 and below the S&P 500 P/E ratio of 17.2.

TheStreet Ratings rates Amsurg as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in stock price during the past year, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Amsurg Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

If you liked this article you might like

Battered Pharma Stocks Bounce Back, Could Boost Retirement Portfolios

'Mad Money' Lightning Round: Kroger, Dunkin' Brands

Jim Cramer's 'Mad Money' Recap: Trump Trade War Could Hit U.S. Car, Apple iPhone Sales

Analysts' Actions -- Tableau, Nucor, Pfizer, Square and More

Mednax Remains Unlikely Target as Medical Mergers Gain Steam